Skip to Content

Grant Support

Faculty/Role Funding Agency Title
Capitini, Christian M (PI) DHHS, PHS, National Institutes of Health Inhibiting STAT1 as a Novel Graft-Versus-Host/Graft-Versus-Leukemia Therapy
Capitini, Christian M (PI) Novartis A Phase II, Single Arm, Multicenter Trial to Determine the Efficacy and Safety of CTL019 in Pediatric Patients with Relapsed and Refractory B-cell Acute Lymphoblastic Leukemia
Capitini, Christian M (PI) Midwest Athletes Against Childhood Cancer Exploitation of the STAT1-BCL2 Axis to Dissect GVL from GVHD
Capitini, Christian M
Otto, Mario (Young Investigators)
Stand Up 2 Cancer Foundations Immunogenomics to Create New Therapies for High-risk Childhood Cancers
Capitini, Christian M (Mentor) American Society of Hematology Hematology Opportunities for the Next Generation of Research Scientists (Tara Gavcovich)
Capitini, Christian M (PI) Vilas (William F) Trust Estate Vilas Faculty Early Career Investigator Award
Capitini, Christian M (Mentor) St Baldrick’s Foundation Summer fellowship support (Tara Gavcovich)
Capitini, Christian M (PI) American Association of Immunologists Careers in Immunology Fellowship (M. Bouchlaka)
Capitini, Christian M (PI) UW SMPH/ICTR Centennial Scholar
Capitini, Christian M (PI) UWF - University of Wisconsin Foundation MEMS as Protection from GVHD (ICTR pilot)
DeSantes, Kenneth B (PI) Children's Hospital of Philadelphia COG Per Case & Specimen Reimbursement
DeSantes, Kenneth B (PI) Children's Hospital of Philadelphia CCOP: COG Per Case Reimbursement
DeSantes, Kenneth B (PI) National Marrow Donor Program 11 TREO: A Phase II Study of Treosulfan/Fludarabine/Low Dose Total Body Irradiation as a Preparative Regiment for Children with AML/MDS Undergoing Allogeneic Hematopoietic Cell Transplantation
DeSantes, Kenneth B (PI) Children's Hospital of Philadelphia COG Workload Intensity
DeSantes, Kenneth B (PI) Children's Hospital of Philadelphia ANBL0532 CTSU PCR
DeSantes, Kenneth B (PI) Children's Hospital of Philadelphia ADVL1122: A Phase 2 Multi-Center, Historically-Controlled Study of Dasatinib Added to Standard Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
DeSantes, Kenneth B (PI) Children's Hospital of Philadelphia AAML1031: A Phase III Randomized Trial for Patients with de novo AML using Bortezomib (NSC# 681239) and Sorafenib (BAY 43-9006, NSC# 724772) for Patients with High Allelic Ratio FLT2/ITD - AAML1031
DeSantes, Kenneth B (PI) Children's Hospital of Philadelphia PIDTC Per Case Reimbursement
DeSantes, Kenneth B (PI) Children's Hospital of Philadelphia A Phase II Study of MLN8237 (IND#102984), a Selective Aurora A Kinase Inhibitor in Children with Recurrent/Refractory Solid Tumors and Leukemias (ADVL0921)
DeSantes, Kenneth B (PI) Children's Hospital of Philadelphia ACNS1021 - PFIZER NO. WS281593-48
DeSantes, Kenneth B (PI) Children's Hospital of Philadelphia ANHL1131 - Intergroup Trial for Children or Adolescents with B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients
DeSantes, Kenneth B (PI) Children's Hospital of Philadelphia AALL1131 - A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND #73789, NSC #606869) in the Very High Risk Stratum
DeSantes, Kenneth B (PI) Children's Hospital of Philadelphia St. Baldrick's Supplemental Per Case Reimbursement (COG)
DeSantes, Kenneth B (PI) Solving Kids’ Cancer Phase I Trial of Ex-Vivo Expanded Haploidentical NK Cells and Hu14.18-IL2 for Children with Relapsed/Refractory Neuroblastoma
DeSantes, Kenneth B (PI)
Otto, Mario (co-I)
Sondel, Paul M (collaborator)
Midwest Athletes Against Childhood Cancer Alpha/Beta T-Cell Depleted Haploidentical Transplantation with Post-Transplant Zoledronic Acid to Treat Recurrent or Refractory Pediatric Malignancies
DeSantes, Kenneth B (PI)
Sondel, Paul M (co-I)
Midwest Athletes Against Childhood Cancer Support for Research Data Management
DeSantes, Kenneth B (co-I) with
Hei, Derek (PI)
National Institutes of Health PACT
Otto, Mario (PI) Hyundai Hope on Wheels A Novel Phospholipid Ether Analog to Combine Targeted Molecular Radiotherapy and Immunotherapy in Pediatric Solid Tumors
Otto, Mario (PI) NIH-NCI “A Cancer-targeted Phospholipid Ether Analog for Molecular Radiotherapy of Pediatric Solid Tumors
Otto, Mario (PI) Midwest Athletes Against Childhood Cancer Effect of Zoledronate on Engraftment and t-cell Development After TCR alpha-ß/CD19-depleted Hematopoietic Stem Cell Transplantation
Otto, Mario (PI) Midwest Athletes Against Childhood Cancer A Tumor-selective Alkyl Phospholipid Analog for the Treatment of Pediatric Solid Malignancies
Otto, Mario (co-PI) Midwest Athletes Against Childhood Cancer Alpha/beta t-cell Depleted Haploidentical Transplantation with Post-transplant Zoledronic Acid to Treat Recurrent or Refractory Pediatric Malignancies
Puccetti, Diane M (PI) Midwest Athletes Against Childhood Cancer Psychosocial Aspects of Ending Treatment & Long-Term Survival of Pediatric Cancer Patients: A Joint Proposal
Sondel, Paul M (PI) NIH/NCI Enhancing antibody-directed innate immunity to improve cancer outcome
Sondel, Paul M (co-PI) Solving Kids Cancer & Southampton General Hospital, UK Phase I study of 131-1 mIBG followed by Nivolumab and ch14.18/CHO in children with relapsed/refractory neuroblastoma
Sondel, Paul M (PI) St. Jude Children’s Research Hospital Neuroblastoma protocol 2012: therapy for children with advanced stage high risk neuroblatoma
Sondel, Paul M (co-I) American Cancer Society The role of TPL2 in regulating macrophage-myeloma tumor cell interactions
Sondel, Paul M (PI) Alex’s Lemonade Stand Identifying how pre-existing anti-therapeutic antibodies (PATA) are associated with better outcome in a clinical trial of ADCC-inducing anti-GD2 mAb
Sondel, Paul M (PI) St. Jude Children’s Research Hospital A phase I trial of the humanized anti-GD2 antibody in children and adolescents with neuroblastoma or melanoma
Sondel, Paul M (collaborator) MACC Fund Treatment of relapsed or refractory neuroblastoma with ex-vivo activated and expanded haploidentical NK cells and Hu14.18-IL2
Sondel, Paul M (PI) MACC Fund Enhancing immunocytokine efficacy in neuroblastoma: synergy with radiation therapy (RT) and development of 2nd generation immunocytokines (ICs)
Sondel, Paul M (collaborator) MACC Fund Alpha/beta t-cell depleted haploidentical transplantation with post-transplant zoledronic acid to treat recurrent or refractory pediatric malignancies
Sondel, Paul M NIH/NCATS Clinical and translational science award
Sondel, Paul M (PI) St. Baldrick’s Foundation Finding the target of beneficial anti-therapeutic antibodies
Sondel, Paul M (PI) NIH/NCATS & UW Carbone Cancer Center Murine cancer models for testing in situ vaccination strategies
Sondel, Paul M (co-I) UW Carbone Cancer Center NK cell activation with anti-Ly49 antibody and antiCD40/CPG for immunotherapy of pancreatic cancer
Sondel, Paul M (local PI) American Association for Cancer Research (AACR), St. Baldrick’s Foundation, Stand Up 2 Cancer Foundation & Children’s Hospital of Philadelphia Immunogenomics to create new therapeutics for high risk childhood cancers
Sondel, Paul M (mentor) Howard Hughes Medical Student Research Fellowship Description and characterization of endogenous antibodies found in some cancer patients that are capable of recognizing various monoclonal antibodies used in cancer immunotherapy
Sondel, Paul M (PI) NCI-Clinical Immunotherapy Trials Network Membership in national consortium
Sondel, Paul M (PI) University of Wisconsin Pilot Research Award Testing molecular variants of imatinib and dasatininib for antitumor vs. immunosuppressive effects

Last updated: 01/04/2016
webmaster [at] pediatrics [dot] wisc [dot] edu
Copyright © 2016 The Board of Regents of the University of Wisconsin System